drugset / Trial / NCT04593329

Efficacy and Safety of Tiradentes Association in the Treatment of Acute Pain

NCT04593329

Phase 2 Withdrawn EMS
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to evaluate the efficacy and safety of Tiradentes association in adolescents and adults with acute pain.

Timeline

Start
2023-03
Primary completion
2023-08
Completion
2023-12

Drugs

EvaluationDrugModalityDoseRoute
Subject TIRADENTES ASSOCIATION Unknown Oral
Comparator Tramadol Other / unclassified 50 mg Oral
Comparator dipyrone Unknown 500 mg Oral

Indications

No indication recorded.